NEW YORK / RankWire.AI / – New York City health officials identified Legionella DNA in a Yankee Stadium cooling tower during an investigation into an outbreak in the South Bronx. As of Tuesday night, the city confirmed 11 cases of Legionnaires’ disease. One individual has died, and three patients remain hospitalized. The New York City Health Department detected preliminary positive PCR results in 10 out of 24 cooling towers sampled across ZIP codes 10451 and 10456.

Severe personnel and funding deficits are bottlenecking emergency containment efforts for the Democratic Republic of the Congo’s expanding Ebola epidemic. Driven by the Bundibugyo virus species, the outbreak has swept through six provinces, recording over 6,000 cases and 3,175 fatalities. The World Health Organization is calling on international donors for urgent financial assistance to deploy frontline medical teams and increase isolation capacity across remote eastern regions. Epidemiologists examine disease surveillance tracking charts and regional maps on displays. To manage the geographic spread, health authorities have adopted a decentralized treatment approach aimed at establishing care facilities nearer to rural communities affected by the outbreak. Response teams have set up nearly 1,400 treatment beds across 59 specialized operational centers. Nevertheless, technical evaluations show that an additional 1,600 beds are needed to reach the goal of 3,000 total beds. Achieving this target will require recruiting and training approximately 5,000 more medical staff, supporting the 9,000 health workers necessary for comprehensive operational coverage. Limited operational funds and resource shortages further hinder efforts to expand activities in remote provinces. On average, daily costs for personal protective equipment (PPE) amount to $25 per healthcare worker entering high-risk patient isolation zones. Running a standard 50-bed treatment facility costs around $500,000, creating significant financial pressures amid declining global donor contributions. Data shared via the Emirates News Agency underscores that fully operational treatment centers and adequately trained personnel are critical to increasing patient survival rates and halting transmission chains

The World Health Organization has called for an expanded Ebola response in the Democratic Republic of the Congo amid ongoing transmission in multiple provinces. By September 1, the government reported a total of 6,250 confirmed cases and 3,039 fatalities. The outbreak has impacted 60 health zones across six provinces. Authorities have also documented 1,439 recoveries, with a case fatality rate of 48.6%. Health teams in Congo continue Ebola testing, contact tracing and treatment. Congo’s Bundibugyo Ebola outbreak has become its largest and most lethal to date. It ranks as the second-largest Ebola outbreak ever recorded, surpassed only by the 2014-2016 epidemic in West Africa. Ituri province remains the primary hub of transmission, accounting for roughly 85% of confirmed cases and 88% of reported deaths, making it the most severely affected region during this health crisis. WHO Director-General Tedros Adhanom Ghebreyesus stated that health teams have yet to trace all chains of transmission. Many recent fatalities involved individuals not on known contact lists. The presence of community deaths and unsafe burials continues to hinder efforts to contain the virus. According to Africa CDC, over 60% of fatalities in the past week occurred in communities rather than healthcare facilities. Health agencies step up Ebola containment measures The World Health Organization has increased laboratory testing, treatment capacity, and field operations in affected regions. Over 330 tonnes of emergency supplies have been shipped, and more than 300

Health Minister Samuel-Roger Kamba confirmed that the government deployed an initial supply of the Ervebo vaccine under a compassionate-use framework across impacted eastern provinces to safeguard essential personnel and help disrupt viral transmission chains. Authorities are administering the Ervebo vaccine under a compassionate-use framework while researchers gather observational data on its effectiveness against the circulating viral strain. Officials highlight that early detection, combined with isolation protocols and supportive treatment, remains critical for improving patient survival rates.